Education:
Saint Louis University
Biology major
B.S., 2017
MSTP Student Governance:
- Student Advisory Committee, 2021-23
Thesis Advisors: Jeff Miller, M.D. and Paulo Provenzano, Ph.D.
Publications
Dodhiawala PB, Pribyl K, Larson J, Vakayil V, Chandrashekar M, Lord A, Welbig J, Zantek ND, Martin D, Harmon JV. Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study. Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231198038. PMCID: PMC10475228
Faget DV, Luo X, Inkman MJ, Ren Q, Su X, Ding K, Waters MR, Raut GK, Pandey G, Dodhiawala PB, Ramalho-Oliveira R, Ye J, Cole T, Murali B, Zheleznyak A, Shokeen M, Weiss KR, Monahan JB, DeSelm CJ, Lee AV, Oesterreich S, Weilbaecher KN, Zhang J, DeNardo DG, Stewart SA. p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy. Cancer Discov. 2023 Jun 2;13(6):1454-1477. PMCID: PMC10238649
Bansod S, Dodhiawala PB, Lim KH. Cancers (Basel). Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities. 2021 Oct 31;13(21):5481. PMCID: PMC8582583. Review.
For work prior to the UMN MSTP:
Khurana N, Dodhiawala PB, Bulle A, Lim KH. Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer. Cancers (Basel). 2020 Sep 19;12(9):2675. Review. PMCID: PMC7564842
Dodhiawala PB, Khurana N, Zhang D, Cheng Y, Li L, Wei Q, Seehra K, Jiang H, Grierson PM, Wang-Gillam A, Lim KH. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations. J Clin Invest. 2020 Sep 1;130(9):4771-4790. PMCID: PMC7456254
Jin X, Starke S, Li Y, Sethupathi S, Kung G, Dodhiawala P, Wang Y. Nitrogen Starvation-induced Phosphorylation of Ras1 Protein and Its Potential Role in Nutrient Signaling and Stress Response. J Biol Chem. 2016 Jul 29;291(31):16231-9. PMCID: PMC4965571
Jiang H, Xu M, Li L, Grierson P, Dodhiawala P, Highkin M, Zhang D, Li Q, Wang-Gillam A, Lim KH. Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Mol Cancer Ther. 2018 Oct;17(10):2144-2155. PMCID: PMC6168412
